Evaluation of lipoprotein-associated phospholipase A2 levels in association with carotid atherosclerosis in patients with coronary artery disease

被引:0
|
作者
Osmankulova, G. [1 ]
Kurmanbekova, B. T. [1 ]
Noruzbaeva, A. M. [1 ]
机构
[1] Natl Ctr Cardiol & Therapy, Bishkek, Kyrgyzstan
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P893
引用
收藏
页码:199 / 200
页数:2
相关论文
共 50 条
  • [31] Association between Lipoprotein-Associated Phospholipase A2 Gene Polymorphism and Coronary Artery Disease in the Chinese Han Population
    Li, Liyun
    Qi, Liping
    Lv, Naqiang
    Gao, Qian
    Cheng, Yanmei
    Wei, Yingjie
    Ye, Jue
    Yan, Xiaowei
    Dang, Aimin
    ANNALS OF HUMAN GENETICS, 2011, 75 : 605 - 611
  • [32] The role of lipoprotein-associated phospholipase A2 as a marker for atherosclerosis
    Virani S.S.
    Nambi V.
    Current Atherosclerosis Reports, 2007, 9 (2) : 97 - 103
  • [33] Examining the Role of Lipoprotein-Associated Phospholipase A2 in Atherosclerosis
    Gilpatrick, Timothy Edward
    Tomczak, Jonathan
    Bahnson, Brian J.
    FASEB JOURNAL, 2012, 26
  • [34] LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 LEVELS, ENDOTHELIAL DYSFUNCTION AND ARTERIAL STIFFNESS IN PATIENTS WITH STABLE CORONARY ARTERY DISEASELIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 LEVELS, ENDOTHELIAL DYSFUNCTION AND ARTERIAL STIFFNESS IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE
    Oikonomou, Evangelos
    Mourouzis, Konstantinos
    Siasos, Gerasimos
    Zaromitidou, Marina
    Tsigkou, Vicky
    Bletsa, Evanthia
    Mystakidi, Vasiliki Chara
    Goliopoulou, Athina
    Papanikolaou, Paraskevi
    Stampouloglou, Panagiota
    Vavuranakis, Manolis
    Tousoulis, Dimitris
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 150 - 150
  • [35] Association of lipoprotein-associated phospholipase A2 levels with coronary artery disease risk factors, angiographic coronary artery disease, and major adverse events at follow-up
    Brilakis, ES
    McConnell, JP
    Lennon, RJ
    Elesber, AA
    Meyer, JG
    Berger, PB
    EUROPEAN HEART JOURNAL, 2005, 26 (02) : 137 - 144
  • [36] Lipoprotein-Associated Phospholipase A2 Activity Predicts Progression of Subclinical Coronary Atherosclerosis
    Kinney, Gregory L.
    Snell-Bergeon, Janet K.
    Maahs, David M.
    Eckel, Robert H.
    Ehrlich, James
    Rewers, Marian
    Hokanson, John E.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2011, 13 (03) : 381 - 387
  • [37] New insights into the role of lipoprotein(a)-associated lipoprotein-associated phospholipase A2 in atherosclerosis and cardiovascular disease
    Tsimikas, Sotirios
    Tsironis, Loukas D.
    Tselepis, Alexandros D.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (10) : 2094 - 2099
  • [38] Elevated Lipoprotein-Associated Phospholipase A2 Is Associated With Intracranial Atherosclerosis
    Wang, Yuan
    Liu, Gang
    Song, Haiqing
    Cao, Catherine
    Ji, Xunming
    Cao, Guodong
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [39] Lipoprotein-associated phospholipase A2 independently predicts the angiographic diagnosis of coronary artery disease and coronary death
    May, Heidi T.
    Horne, Benjamin D.
    Anderson, Jeffrey L.
    Wolfert, Robert L.
    Muhlestein, Joseph B.
    Renlund, Dale G.
    Clarke, Jessica L.
    Kolek, Matthew J.
    Bair, Tami L.
    Pearson, Robert R.
    Sudhir, Krishnankutty
    Carlquist, John F.
    AMERICAN HEART JOURNAL, 2006, 152 (05) : 997 - 1003
  • [40] Association between the Lipoprotein-Associated Phospholipase A2 Activity and the Progression of Subclinical Atherosclerosis
    Liu, Jing
    Wang, Wei
    Qi, Yue
    Yong, Qiang
    Zhou, Guanghua
    Wang, Miao
    Sun, Jiayi
    Liu, Jun
    Jia, Zhangrong
    Zhao, Dong
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2014, 21 (06) : 532 - 542